Azenta Posts 5% Revenue Growth in Fiscal 2026, Eyes Continued Gains
Azenta reported 5% year-over-year revenue growth for both Q4 and full fiscal 2026, with organic growth of 2% and stronger targets set for fiscal 2027.
Azenta Inc. reported fourth-quarter and full-year results for fiscal 2026, ended September 30, 2026, posting revenue growth of 5% year over year for both the final quarter and the full fiscal year. On an organic basis, growth came in at 2% for both periods, reflecting steady underlying demand across the company's core operations.
Looking ahead, Azenta projected fiscal 2027 reported revenue in a range of $648 million to $660 million, signaling management's expectation of continued top-line expansion. The company also forecast organic revenue growth of between 3% and 5% for the coming fiscal year, an acceleration from the 2% organic rate recorded in fiscal 2026.
Read more Cisco Posts Record $18.5B Revenue, EPS Surges in Q1 2027 →
The guidance range suggests Azenta anticipates both acquisitive and underlying business contributions driving incremental gains in the year ahead. The projected step-up in organic growth indicates that management sees improving demand conditions or operational momentum beyond what currency or deal activity alone would provide.
Azenta's results and forward outlook position the life sciences tools and services provider within a broader industry landscape where sample management and genomic services companies have faced varied demand trends following elevated post-pandemic activity levels. The fiscal 2027 targets will be closely watched by investors gauging the pace of recovery in research spending.
Continue reading at Earnings.
